Sample overview
| Project Name |
TCGA-LAML
|
| GSE ID |
GSE243227
|
| GSM ID |
GSM7781088
|
| Cell Line |
K562
|
| Tissue type |
None
|
| Disease Type |
K562:Kasumi-1 100:1
|
| PMID |
38167262
|
| Initial gene number |
36601
|
| Initial cell number |
11946
|
| Post-QC gene number |
8087
|
| Post-QC cell number |
6049
|
Bulk-to-ScRNA-seq Label Transfer
Bulk phenotype-associated subpopulations
Reference-Based Annotation
Differentially expressed genes
Overall Survival : Cluster
vs
There are no results of the analysis here
Overall Survival : Cluster
vs ( + )
There are no results of the analysis here
Clinical Stage : Cluster
vs
There
are no results of the analysis here
Tumor Size : Cluster
vs
There
are no results of the analysis here
Lymph Node Involvement : Cluster
vs
There
are no results of the analysis here
Distant Metastasis : Cluster
vs
There
are no results of the analysis here
Cell-Cell communications ( Survival-Associated Subpopulations Across Cell Types )
Cell Population Signaling and Communication
Ligand-Receptor-Mediated Cell-Cell Interactions
| Sending Cell Type |
Ligand |
Receiving Cell Type |
Receptor |
Score |
P-value |
Pathway Name |
Function |
Evidence |
| Erythrocytes(Nos)_source |
NAMPT_ligand |
Erythrocytes(Nos)_target |
ITGA5_ITGB1_receptor |
8.307e-04 |
0.0 |
VISFATIN |
Secreted Signaling |
PMID: 28490838 |
| HSC(Nos)_source |
NAMPT_ligand |
Erythrocytes(Nos)_target |
ITGA5_ITGB1_receptor |
1.414e-04 |
0.0 |
VISFATIN |
Secreted Signaling |
PMID: 28490838 |
| Erythrocytes(Nos)_source |
GRN_ligand |
Erythrocytes(Nos)_target |
SORT1_receptor |
1.983e-05 |
0.0 |
GRN |
Secreted Signaling |
PMID: 29555433 |
| HSC(Nos)_source |
GRN_ligand |
Erythrocytes(Nos)_target |
SORT1_receptor |
5.083e-06 |
0.0 |
GRN |
Secreted Signaling |
PMID: 29555433 |
| Erythrocytes(Nos)_source |
MPZL1_ligand |
Erythrocytes(Nos)_target |
MPZL1_receptor |
8.203e-09 |
0.0 |
MPZ |
Cell-Cell Contact |
KEGG: hsa04514 |